Literature DB >> 27390007

Antibody-dependent enhancement of SARS coronavirus infection and its role in the pathogenesis of SARS.

M S Yip1, H L Leung1, P H Li1, C Y Cheung2, I Dutry1, D Li1, M Daëron3, R Bruzzone4, J Sm Peiris1, M Jaume1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27390007

Source DB:  PubMed          Journal:  Hong Kong Med J        ISSN： 1024-2708            Impact factor:   2.227


× No keyword cloud information.
  51 in total

1.  Bispecific IgG neutralizes SARS-CoV-2 variants and prevents escape in mice.

Authors:  Raoul De Gasparo; Mattia Pedotti; Luca Simonelli; Petr Nickl; Frauke Muecksch; Irene Cassaniti; Elena Percivalle; Julio C C Lorenzi; Federica Mazzola; Davide Magrì; Tereza Michalcikova; Jan Haviernik; Vaclav Honig; Blanka Mrazkova; Natalie Polakova; Andrea Fortova; Jolana Tureckova; Veronika Iatsiuk; Salvatore Di Girolamo; Martin Palus; Dagmar Zudova; Petr Bednar; Ivana Bukova; Filippo Bianchini; Dora Mehn; Radim Nencka; Petra Strakova; Oto Pavlis; Jan Rozman; Sabrina Gioria; Josè Camilla Sammartino; Federica Giardina; Stefano Gaiarsa; Qiang Pan-Hammarström; Christopher O Barnes; Pamela J Bjorkman; Luigi Calzolai; Antonio Piralla; Fausto Baldanti; Michel C Nussenzweig; Paul D Bieniasz; Theodora Hatziioannou; Jan Prochazka; Radislav Sedlacek; Davide F Robbiani; Daniel Ruzek; Luca Varani
Journal:  Nature       Date:  2021-03-25       Impact factor: 49.962

2.  A perspective on potential antibody-dependent enhancement of SARS-CoV-2.

Authors:  Ann M Arvin; Katja Fink; Michael A Schmid; Andrea Cathcart; Roberto Spreafico; Colin Havenar-Daughton; Antonio Lanzavecchia; Davide Corti; Herbert W Virgin
Journal:  Nature       Date:  2020-07-13       Impact factor: 49.962

3.  Product of natural evolution (SARS, MERS, and SARS-CoV-2); deadly diseases, from SARS to SARS-CoV-2.

Authors:  Mohamad Hesam Shahrajabian; Wenli Sun; Qi Cheng
Journal:  Hum Vaccin Immunother       Date:  2020-08-12       Impact factor: 3.452

Review 4.  Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies.

Authors:  Wen Shi Lee; Adam K Wheatley; Stephen J Kent; Brandon J DeKosky
Journal:  Nat Microbiol       Date:  2020-09-09       Impact factor: 17.745

5.  Development and characterization of two equine formulations towards SARS-CoV-2 proteins for the potential treatment of COVID-19.

Authors:  Guillermo León; María Herrera; Mariángela Vargas; Mauricio Arguedas; Andrés Sánchez; Álvaro Segura; Aarón Gómez; Gabriela Solano; Eugenia Corrales-Aguilar; Kenneth Risner; Aarthi Narayanan; Charles Bailey; Mauren Villalta; Andrés Hernández; Adriana Sánchez; Daniel Cordero; Daniela Solano; Gina Durán; Eduardo Segura; Maykel Cerdas; Deibid Umaña; Edwin Moscoso; Ricardo Estrada; Jairo Gutiérrez; Marcos Méndez; Ana Cecilia Castillo; Laura Sánchez; Ronald Sánchez; José María Gutiérrez; Cecilia Díaz; Alberto Alape
Journal:  Sci Rep       Date:  2021-05-10       Impact factor: 4.379

6.  Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) study: an observational cohort study of SARS-CoV-2 infection and vaccination in healthcare workers.

Authors:  Belinda M Jackson-Thompson; Emilie Goguet; Eric D Laing; Cara H Olsen; Simon Pollett; K Monique Hollis-Perry; Santina E Maiolatesi; Luca Illinik; Kathleen F Ramsey; Anatalio E Reyes; Yolanda Alcorta; Mimi A Wong; Julian Davies; Orlando Ortega; Edward Parmelee; Alyssa R Lindrose; Matthew Moser; Elizabeth Graydon; Andrew G Letizia; Christopher A Duplessis; Anuradha Ganesan; Kathleen P Pratt; Allison M Malloy; David W Scott; Stephen K Anderson; Andrew L Snow; Clifton L Dalgard; John H Powers; David Tribble; Timothy H Burgess; Christopher C Broder; Edward Mitre
Journal:  BMC Infect Dis       Date:  2021-06-09       Impact factor: 3.090

7.  In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies.

Authors:  Dapeng Li; Robert J Edwards; Kartik Manne; David R Martinez; Alexandra Schäfer; S Munir Alam; Kevin Wiehe; Xiaozhi Lu; Robert Parks; Laura L Sutherland; Thomas H Oguin; Charlene McDanal; Lautaro G Perez; Katayoun Mansouri; Sophie M C Gobeil; Katarzyna Janowska; Victoria Stalls; Megan Kopp; Fangping Cai; Esther Lee; Andrew Foulger; Giovanna E Hernandez; Aja Sanzone; Kedamawit Tilahun; Chuancang Jiang; Longping V Tse; Kevin W Bock; Mahnaz Minai; Bianca M Nagata; Kenneth Cronin; Victoria Gee-Lai; Margaret Deyton; Maggie Barr; Tarra Von Holle; Andrew N Macintyre; Erica Stover; Jared Feldman; Blake M Hauser; Timothy M Caradonna; Trevor D Scobey; Wes Rountree; Yunfei Wang; M Anthony Moody; Derek W Cain; C Todd DeMarco; Thomas N Denny; Christopher W Woods; Elizabeth W Petzold; Aaron G Schmidt; I-Ting Teng; Tongqing Zhou; Peter D Kwong; John R Mascola; Barney S Graham; Ian N Moore; Robert Seder; Hanne Andersen; Mark G Lewis; David C Montefiori; Gregory D Sempowski; Ralph S Baric; Priyamvada Acharya; Barton F Haynes; Kevin O Saunders
Journal:  Cell       Date:  2021-06-18       Impact factor: 66.850

8.  A recombinant Lactobacillus plantarum strain expressing the spike protein of SARS-CoV-2.

Authors:  Maopeng Wang; Tingting Fu; Jiayi Hao; Letian Li; Mingyao Tian; Ningyi Jin; Linzhu Ren; Chang Li
Journal:  Int J Biol Macromol       Date:  2020-05-30       Impact factor: 6.953

9.  Defining protective epitopes for COVID-19 vaccination models.

Authors:  Nevio Cimolai
Journal:  J Med Virol       Date:  2020-06-02       Impact factor: 20.693

10.  Preliminary Analysis of B- and T-Cell Responses to SARS-CoV-2.

Authors:  Li-Xia Zhang; Shu-Yan Miao; Zhong-Hua Qin; Jun-Pin Wu; Huai-Yong Chen; Hai-Bai Sun; Yi Xie; Yan-Qing Du; Jun Shen
Journal:  Mol Diagn Ther       Date:  2020-10       Impact factor: 4.476
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.